Technical Analysis for ATXI - Avenue Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 11.47 3.38% 0.38
ATXI closed up 3.38 percent on Friday, May 29, 2020, on 1.89 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical ATXI trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
New 52 Week High Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Up 5 Days in a Row Strength 0.00%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.
Pharmaceutical Drugs Chemical Compounds Analgesics Neurochemistry Pharmacokinetics Hepatotoxins Amines Opioid Paracetamol

Is ATXI a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.83
52 Week Low 4.9625
Average Volume 53,352
200-Day Moving Average 7.71
50-Day Moving Average 9.18
20-Day Moving Average 10.16
10-Day Moving Average 10.58
Average True Range 0.62
ADX 33.15
+DI 31.23
-DI 7.20
Chandelier Exit (Long, 3 ATRs ) 9.96
Chandelier Exit (Short, 3 ATRs ) 10.80
Upper Bollinger Band 11.26
Lower Bollinger Band 9.06
Percent B (%b) 1.09
BandWidth 21.74
MACD Line 0.52
MACD Signal Line 0.42
MACD Histogram 0.1005
Fundamentals Value
Market Cap 115.17 Million
Num Shares 10 Million
EPS -0.44
Price-to-Earnings (P/E) Ratio -26.07
Price-to-Sales 0.00
Price-to-Book 1.57
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.90
Resistance 3 (R3) 12.86 12.35 12.66
Resistance 2 (R2) 12.35 11.98 12.36 12.58
Resistance 1 (R1) 11.91 11.76 12.13 11.95 12.50
Pivot Point 11.39 11.39 11.50 11.41 11.39
Support 1 (S1) 10.95 11.03 11.17 10.99 10.44
Support 2 (S2) 10.44 10.80 10.46 10.36
Support 3 (S3) 10.00 10.44 10.28
Support 4 (S4) 10.04